Membrane Crystallization Separation
continuous flow
mAbs production
innovative Membrane Crystallization Technology
new Continuous Template
scale continuous prototype
cost of chromatography media
Membrane Crystallizer
single membrane-crystallization unit
purification of biopharmaceuticals
emerging Continuous Manufacturing Paradigm
high-throughput mAb crystallization screening
high-purity solid formulation of mAbs
Downstream Processing of Monoclonal Antibodies
DSP platform
Traditional DSP
unprecedented purification
technology scale
batch chromatography
replacement of chromatography
purification of proteins
costs
total production cost of anti-cancer monoclonal antibodies
high buffer requirements
intense Downstream Processing
large footprint
recognition of QS
manufacturing efficiencies
g mAb
fold footprint reduction
selective nanotemplate-recognitions
storage of resin studies
specific molecular recognition ability
advanced control of selective heterogeneous nucleation
reuse
operations
wide range of conditions
development of tailored macroporous fluoropolymer membranes
design of multilevel microfluidic devices
D-nanotemplates
complex solutions
ambitious combination
preserved biological activity
order
fermentation broth
AMECRYS Network
binding capacity
disadvantages
GMP compliance
instance
manufacture of commercial products
concept
time
Major research challenges
chip
synthesis
CapEx